Literature DB >> 8504780

Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984.

W A Hauser1, J F Annegers, L T Kurland.   

Abstract

The incidence of epilepsy and of all unprovoked seizures was determined for residents of Rochester, Minnesota U.S.A. from 1935 through 1984. Age-adjusted incidence of epilepsy was 44 per 100,000 person-years. Incidence in males was significantly higher than in females and was high in the first year of life but highest in persons aged > or = 75 years. Sixty percent of new cases had epilepsy manifested by partial seizures, and two thirds had no clearly identified antecedent. Cerebrovascular disease was the most commonly identified antecedent, accounting for 11% of cases. Neurologic deficits from birth, mental retardation and/or cerebral palsy, observed in 8% of cases, was the next most frequently identified preexisting condition. The cumulative incidence of epilepsy through age 74 years was 3.1%. The age-adjusted incidence of all unprovoked seizures was 61 per 100,000 person-years. Age- and gender-specific incidence trends were similar to those of epilepsy, but a higher proportion of cases was of unknown etiology and was characterized by generalized onset seizures. The cumulative incidence of all unprovoked seizures was 4.1% through age 74 years. With time, the incidence of epilepsy and of unprovoked seizures decreased in children and increased in the elderly.

Entities:  

Mesh:

Year:  1993        PMID: 8504780     DOI: 10.1111/j.1528-1157.1993.tb02586.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  395 in total

1.  A new locus for generalized epilepsy with febrile seizures plus maps to chromosome 2.

Authors:  I Lopes-Cendes; I E Scheffer; S F Berkovic; M Rousseau; E Andermann; G A Rouleau
Journal:  Am J Hum Genet       Date:  2000-02       Impact factor: 11.025

2.  Seizure disorders: Part 1. Classification and diagnosis.

Authors:  S Kammerman; L Wasserman
Journal:  West J Med       Date:  2001-08

3.  Subacute seizure incidence in thrombolysis-treated ischemic stroke patients.

Authors:  P Couillard; M A Almekhlafi; A Irvine; N Jetté; J Pow; C St Germaine-Smith; N Pillay; M D Hill
Journal:  Neurocrit Care       Date:  2012-04       Impact factor: 3.210

4.  Epileptic seizures from abnormal networks: why some seizures defy predictability.

Authors:  William S Anderson; Feraz Azhar; Pawel Kudela; Gregory K Bergey; Piotr J Franaszczuk
Journal:  Epilepsy Res       Date:  2011-12-12       Impact factor: 3.045

Review 5.  Seizures and epilepsy in Alzheimer's disease.

Authors:  Daniel Friedman; Lawrence S Honig; Nikolaos Scarmeas
Journal:  CNS Neurosci Ther       Date:  2011-06-07       Impact factor: 5.243

6.  Achyranthes aspera Attenuates epilepsy in experimental animals: possible involvement of GABAergic mechanism.

Authors:  Gollapalle Lakshminarayanashastry Viswanatha; Marikunte V Venkataranganna; Nunna Bheema Lingeswara Prasad; Ashok Godavarthi
Journal:  Metab Brain Dis       Date:  2017-03-06       Impact factor: 3.584

7.  Association Between Midlife Risk Factors and Late-Onset Epilepsy: Results From the Atherosclerosis Risk in Communities Study.

Authors:  Emily L Johnson; Gregory L Krauss; Alexandra K Lee; Andrea L C Schneider; Jennifer L Dearborn; Anna M Kucharska-Newton; Juebin Huang; Alvaro Alonso; Rebecca F Gottesman
Journal:  JAMA Neurol       Date:  2018-11-01       Impact factor: 18.302

Review 8.  Breakdown of blood brain barrier as a mechanism of post-traumatic epilepsy.

Authors:  Aaron Dadas; Damir Janigro
Journal:  Neurobiol Dis       Date:  2018-07-18       Impact factor: 5.996

Review 9.  Influence of sex hormones on brain excitability and epilepsy.

Authors:  A Verrotti; G Latini; R Manco; M De Simone; F Chiarelli
Journal:  J Endocrinol Invest       Date:  2007-10       Impact factor: 4.256

10.  NR1 knockdown reveals CA1 injury during a developmental period of high seizure susceptibility despite reduced seizure activity.

Authors:  J Kaur; R Keesey; B Magrys; H Liu; L K Friedman
Journal:  Neuromolecular Med       Date:  2007-08-14       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.